BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
U. Fedeli. Increasing mortality associated with the more recent epidemic wave of hepatitis C virus infection in Northern ItalyJournal of Viral Hepatitis 2018; 25(8): 996 doi: 10.1111/jvh.12893
2
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Marc Sáez-Zafra. Comorbidity, concomitant medication, use of resources and healthcare costs associated with chronic hepatitis C virus carriers in SpainGastroenterología y Hepatología (English Edition) 2018; 41(4): 234 doi: 10.1016/j.gastre.2018.04.015
3
Reham M. Dawood, Mai Abd el-Meguid, Marwa K. Ibrahim, Noha G. Bader El Din, Ahmed Barakat, Khaled El-Wakeel, Mohamed Darwish Ahmed Abd Alla, George Y. Wu, Mostafa K. El Awady. Dysregulation of fibrosis related genes in HCV induced liver diseaseGene 2018; 664: 58 doi: 10.1016/j.gene.2018.04.032
4
Hisham A. Ismail, Doaa Ebrahim, Mohamed A. El-Assal, Mai Abozeid, Eman Abdelsameea. Predictive value of hepcidin in patients with chronic hepatitis C infection among EgyptiansEgyptian Liver Journal 2018; 8(1): 12 doi: 10.1097/01.ELX.0000530863.06773.be
5
A. Erman, A. Sathya, A. Nam, J. M. Bielecki, J. J. Feld, H‐H. Thein, W. W. L. Wong, P. Grootendorst, M. D. Krahn. Estimating chronic hepatitis C prognosis using transient elastography‐based liver stiffness: A systematic review and meta‐analysisJournal of Viral Hepatitis 2018; 25(5): 502 doi: 10.1111/jvh.12846
6
Aparna Vasanthakumar, Justin W. Davis, Manal Abunimeh, Jonas Söderholm, Jiuhong Zha, Emily O. Dumas, Daniel E. Cohen, Jeffrey F. Waring, Martin Lagging, Tatsuo Kanda. Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimensPLOS ONE 2018; 13(5): e0198296 doi: 10.1371/journal.pone.0198296
7
Kellie Young, Benny Liu, Taft Bhuket, Robert J. Wong. Lower Likelihood of Post-Transplant Graft Failure, Death, and Re-Transplantation in the Era of Direct Acting AntiviralsJournal of Clinical and Experimental Hepatology 2020;  doi: 10.1016/j.jceh.2020.02.003
8
Camelia A. Abdel Malak, Tawfeek H. Abelhafez, Ashraf A. Tabll, Mohammad M. Mashaly, Reem El Shenawy, Yasmine S. El-Abd, Maysa H. Shaker, Mostafa K. El-Awady. Neutralizing activity and safety of human monoclonal antibodies against hepatitis C virusHuman Antibodies 2018; 26(3): 127 doi: 10.3233/HAB-170330
9
Kellie Young, Benny Liu, Taft Bhuket, Robert G. Gish, Robert J. Wong. Improved liver transplant waitlist mortality and lower risk of disease progression among chronic hepatitis C patients awaiting liver transplantation after the introduction of direct-acting antiviral therapies in the United StatesJournal of Viral Hepatitis 2019; 26(3): 350 doi: 10.1111/jvh.13039
10
T. Medeiros, N. F. Rosário, G. N. Saraiva, T. G. Andrade, A. A. Silva, J. R. Almeida. Renal safety after one year of sofosbuvir‐based therapy for chronic hepatitis C: A Brazilian “real‐life” studyJournal of Clinical Pharmacy and Therapeutics 2018; 43(5): 707 doi: 10.1111/jcpt.12697
11
Francesca Romana Ponziani, Luca Miele, Annalisa Tortora, Manuele Furnari, Giorgia Bodini, Maurizio Pompili, Antonio Gasbarrini, Edoardo Giovanni Giannini. Treatment of early stage chronic hepatitis C virus infectionExpert Review of Clinical Pharmacology 2018; 11(5): 519 doi: 10.1080/17512433.2018.1447923
12
Maliha Naseer, Harleen Chela, Alhareth AlJuboori. Viral Hepatitis: Chronic Hepatitis C2019; : 25 doi: 10.1007/978-3-030-03757-4_2
13
Melisa Dirchwolf, Sebastián Marciano, Diego H. Giunta, Maria L. Posadas-Martínez, Scott W. Biggins, Andrés E. Ruf. Trends in liver transplantation for hepatitis C in a country with reduced access to direct-acting antiviral agentsClinical Transplantation 2018; 32(4): e13230 doi: 10.1111/ctr.13230
14
Karoly Toth, Ann E. Tollefson, Jacqueline F. Spencer, Baoling Ying, William S.M. Wold. Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compoundsAntiviral Research 2017; 146: 121 doi: 10.1016/j.antiviral.2017.08.002
15
Alejandra Pérez-García, Aitziber Aguinaga, Ana Navascués, Jesús Castilla, Carmen Ezpeleta. Hepatitis C core antigen: Diagnosis and monitoring of patients infected with hepatitis C virusInternational Journal of Infectious Diseases 2019; 89: 131 doi: 10.1016/j.ijid.2019.09.022
16
G Ireland, R Simmons, M Hickman, M Ramsay, C Sabin, S Mandal. Monitoring liver transplant rates in persons diagnosed with hepatitis C: a data linkage study, England 2008 to 2017 Eurosurveillance 2019; 24(41) doi: 10.2807/1560-7917.ES.2019.24.41.1900176
17
Paul Kubes, Craig Jenne. Immune Responses in the LiverAnnual Review of Immunology 2018; 36(1): 247 doi: 10.1146/annurev-immunol-051116-052415
18
Maria Janda, Kari A. Mergenhagen. The Effect of Psychosocial Factors on Success Rates of Hepatitis C TreatmentPsychosomatics 2017; 58(6): 624 doi: 10.1016/j.psym.2017.07.003
19
Luciana D. Silva, Tatiana Bering, Gifone A. Rocha. The impact of nutrition on quality of life of patients with hepatitis CCurrent Opinion in Clinical Nutrition and Metabolic Care 2017; 20(5): 420 doi: 10.1097/MCO.0000000000000396
20
Léonie Petitclerc, Guillaume Gilbert, Bich N. Nguyen, An Tang. Liver Fibrosis Quantification by Magnetic Resonance ImagingTopics in Magnetic Resonance Imaging 2017; : 1 doi: 10.1097/RMR.0000000000000149
21
Valentina Pecoraro, Rita Banzi, Elisabetta Cariani, Johanna Chester, Erica Villa, Roberto D'Amico, Vittorio Bertele', Tommaso Trenti. New Direct-Acting Antivirals for the Treatment of Patients With Hepatitis C Virus Infection: A Systematic Review of Randomized Controlled TrialsJournal of Clinical and Experimental Hepatology 2019; 9(4): 522 doi: 10.1016/j.jceh.2018.07.004
22
Heba Omar, Mohamed Said, Rasha Eletreby, Mai Mehrez, Mohamed Bassam, Zeinab Abdellatif, Adel Hosny, Sherif Megawer, Mona El Amir, Ayman Yosry. Longitudinal assessment of hepatic fibrosis in responders to direct-acting antivirals for recurrent hepatitis C after liver transplantation using noninvasive methodsClinical Transplantation 2018; 32(8): e13334 doi: 10.1111/ctr.13334
23
Maurizio Sessa, Francesca Futura Bernardi, Andrea Vitale, Beniamino Schiavone, Giulia Gritti, Annamaria Mascolo, Michele Bertini, Cristina Scavone, Liberata Sportiello, Francesco Rossi, Annalisa Capuano. Adverse drug reactions during hepatitis C treatment with direct-acting antivirals: The role of medication errors, their impact on treatment discontinuation and their preventability. New insights from the Campania Region (Italy) spontaneous reporting systeJournal of Clinical Pharmacy and Therapeutics 2018; 43(6): 867 doi: 10.1111/jcpt.12744
24
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Marc Sáez-Zafra. Comorbilidad, medicación concomitante, uso de recursos y costes sanitarios asociados a los pacientes portadores del virus de la hepatitis C crónica en EspañaGastroenterología y Hepatología 2018; 41(4): 234 doi: 10.1016/j.gastrohep.2017.11.008
25
Chao He, Xiaojuan Liu, Wei Peng, Chuan Li, Tian-fu Wen. Evaluation the efficacy and safety of simultaneous splenectomy in liver transplantation patientsMedicine 2018; 97(10): e0087 doi: 10.1097/MD.0000000000010087